News

The company will house both its administrative and manufacturing operations within the new headquarters, located at 1600 Harbor Bay Parkway, Alameda, California. Charlie Chi, co-founder and CEO of

Terms of the acquisition are not yet finalized, as completion is subject to a number of conditions including finalization of due diligence and definitive documentation. The company intends

The Named Patient Access Program (NPAP) is a compassionate use drug supply program administered by the Health Sciences Authority (HSA) of Singapore and Drug Control Authority (DCA) of

This study sponsored by PDL BioPharma and conducted at the following Multiple Myeloma Research Consortium (MMRC) Member Institutions: the University of Michigan, Dana-Farber Cancer Institute, University of Chicago,

Dr Mantzoros is an associate professor of medicine at Harvard Medical School and an associate professor in epidemiology at the Harvard School of Public Health. Dr Mantzoros obtained

In a controlled study conducted at MPI Research of Mattawan, Minnesota, Proellex showed no potential for tumor induction as compared to controls in the gross findings. Proellex or

Irribow is a serotonin 5-HT3 receptor antagonist discovered by Astellas. According to the company, Irribow improves abnormal defaecation associated with the acceleration of intestinal transit by inhibiting 5-HT3

The goals of the trial at the Hadassah Medical Center in Ein Kerem, in which ten lupus patients took part, were to demonstrate the safety and efficacy of

Under the terms of the agreement, Amgen will receive a minority equity interest in Gamida Cell in addition to royalty payments from future sales of StemEx for hematological